Further investigation of CDK4/6 inhibitors in HPV-negative HNSCC patients should be developed.517,518 The mechanism of CDK4/6 resistance was also explored, which provided considerate predictive biomarkers in predicting the prognosis of the CDK4/6 response. Here, CDK4 is linked to head and neck squamous cell carcinoma.